Discover
TVRD
Tvardi Therapeutics, Inc.
1.77
2 x 1.79
1 x 1.81
bid
ask
+
0.01
0.85%
01:30 PM
timesize
| Ytd | -58.72% | |
| 1y | -92.64% |
1.77
day range
1.82
1.50
52 week range
43.65
| Open | 1.78 | Prev Close | 1.76 | Low | 1.77 | High | 1.82 | Mkt Cap | 16.65M |
| Vol | 30.26K | Avg Vol | 2.35M | EPS | -3.10 | P/E | -0.57 | Forward P/E | N/A |
| Beta | 0.39 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-08 | 50-d Avg | 2.63 | 200-d Avg | 3.57 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 7.05M | ||
| Research and Development Expense | 4.91M | ||
| Selling, General and Administrative Expense | 2.14M | ||
| Operating Income | -7.05M | ||
| Net Income | -6.80M | ||
| Net Income Common Stock | -6.80M | ||
| Net Income Common Stock (USD) | -6.80M | ||
| Consolidated Income | -6.80M | ||
| Earnings per Basic Share | -0.73 | ||
| Earnings per Basic Share (USD) | -0.73 | ||
| Earnings per Diluted Share | -0.73 | ||
| Earning Before Interest & Taxes (EBIT) | -6.80M | ||
| Earning Before Interest & Taxes (USD) | -6.80M | ||
| Weighted Average Shares | 9.38M | ||
| Weighted Average Shares Diluted | 9.38M | ||
| Balance Sheet | |||
| Cash and Equivalents | 19.85M | ||
| Cash and Equivalents (USD) | 19.85M | ||
| Investments | 5.13M | ||
| Investments Current | 5.13M | ||
| Current Assets | 25.33M | ||
| Property, Plant & Equipment Net | 168.00K | ||
| Total Assets | 25.82M | ||
| Debt Current | 120.00K | ||
| Total Debt | 174.00K | ||
| Current Liabilities | 11.26M | ||
| Debt Non-Current | 54.00K | ||
| Total Liabilities | 11.31M | ||
| Accumulated Retained Earnings (Deficit) | -117.25M | ||
| Accumulated Other Comprehensive Income | 1000 | ||
| Shareholders Equity | 14.51M | ||
| Shareholders Equity (USD) | 14.51M | ||
| Assets Non-Current | 491.00K | ||
| Total Debt (USD) | 174.00K | ||
| Goodwill and Intangible Assets | 306.00K | ||
| Liabilities Non-Current | 54.00K | ||
| Trade and Non-Trade Payables | 4.62M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 44.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -883.00K | ||
| Net Cash Flow from Investing | 4.98M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 4.98M | ||
| Net Cash Flow from Operations | -5.86M | ||
| Share Based Compensation | 370.00K | ||